MetLife Investment Management’s Omega Healthcare OHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.24M | Sell |
151,777
-1,975
| -1% | -$91.5K | 0.03% | 488 |
|
|
2026
Q1 | $6.74M | Buy |
153,752
+1,135
| +0.7% | +$51.8K | 0.03% | 498 |
|
|
2025
Q4 | $6.77M | Sell |
152,617
-7,134
| -4% | -$307K | 0.03% | 491 |
|
|
2025
Q3 | $6.74M | Sell |
159,751
-4,254
| -3% | -$172K | 0.03% | 496 |
|
|
2025
Q2 | $6.01M | Sell |
164,005
-330
| -0.2% | -$12.3K | 0.04% | 503 |
|
|
2025
Q1 | $6.26M | Buy |
164,335
+4,241
| +3% | +$158K | 0.03% | 509 |
|
|
2024
Q4 | $6.06M | Buy |
160,094
+19,200
| +14% | +$767K | 0.03% | 455 |
|
|
2024
Q3 | $5.73M | Buy |
140,894
+3,239
| +2% | +$123K | 0.03% | 454 |
|
|
2024
Q2 | $4.71M | Buy |
137,655
+2,914
| +2% | +$91.8K | 0.03% | 517 |
|
|
2024
Q1 | $4.27M | Sell |
134,741
-3,398
| -2% | -$103K | 0.03% | 579 |
|
|
2023
Q4 | $4.24M | Sell |
138,139
-1,984
| -1% | -$63.7K | 0.03% | 569 |
|
|
2023
Q3 | $4.65M | Sell |
140,123
-319
| -0.2% | -$10.2K | 0.04% | 451 |
|
|
2023
Q2 | $4.31M | Sell |
140,442
-3,219
| -2% | -$93K | 0.03% | 536 |
|
|
2023
Q1 | $3.94M | Sell |
143,661
-3,801
| -3% | -$106K | 0.03% | 600 |
|
|
2022
Q4 | $4.12M | Sell |
147,462
-2,906
| -2% | -$87.7K | 0.03% | 546 |
|
|
2022
Q3 | $4.43M | Sell |
150,368
-2,592
| -2% | -$81.3K | 0.04% | 471 |
|
|
2022
Q2 | $4.31M | Sell |
152,960
-1,582
| -1% | -$45K | 0.03% | 514 |
|
|
2022
Q1 | $4.82M | Buy |
154,542
+38,733
| +33% | +$1.14M | 0.03% | 559 |
|
|
2021
Q4 | $3.43M | Buy |
115,809
+1,052
| +0.9% | +$30.7K | 0.03% | 610 |
|
|
2021
Q3 | $3.44M | Sell |
114,757
-2,846
| -2% | -$97.9K | 0.03% | 568 |
|
|
2021
Q2 | $4.27M | Sell |
117,603
-2,118
| -2% | -$78.6K | 0.04% | 474 |
|
|
2021
Q1 | $4.39M | Sell |
119,721
-4,499
| -4% | -$166K | 0.04% | 461 |
|
|
2020
Q4 | $4.51M | Sell |
124,220
-5,730
| -4% | -$194K | 0.04% | 405 |
|
|
2020
Q3 | $3.89M | Sell |
129,950
-4,796
| -4% | -$150K | 0.04% | 405 |
|
|
2020
Q2 | $4.01M | Buy |
134,746
+9,324
| +7% | +$276K | 0.05% | 388 |
|
|
2020
Q1 | $3.33M | Hold |
125,422
| – | – | 0.05% | 391 |
|
|
2019
Q4 | $5.31M | Sell |
125,422
-532
| -0.4% | -$22.5K | 0.06% | 323 |
|
|
2019
Q3 | $5.26M | Sell |
125,954
-1,144
| -0.9% | -$44.6K | 0.06% | 311 |
|
|
2019
Q2 | $4.67M | Sell |
127,098
-246,357
| -66% | -$8.98M | 0.05% | 380 |
|
|
2019
Q1 | $14.2M | Buy |
373,455
+251,081
| +205% | +$9.31M | 0.04% | 351 |
|
|
2018
Q4 | $4.3M | Sell |
122,374
-273
| -0.2% | -$9.47K | 0.05% | 342 |
|
|
2018
Q3 | $4.02M | Sell |
122,647
-2,173
| -2% | -$69.2K | 0.04% | 477 |
|
|
2018
Q2 | $3.87M | Buy |
124,820
+889
| +0.7% | +$25.4K | 0.05% | 443 |
|
|
2018
Q1 | $3.35M | Sell |
123,931
-1,392
| -1% | -$37.1K | 0.04% | 542 |
|
|
2017
Q4 | $3.45M | Buy |
+125,323
| New | +$3.62M | 0.04% | 555 |
|
Other funds holding OHI
MetLife Investment Management's OHI Position: Q2 2026 in Review
MetLife Investment Management reduced its Omega Healthcare (OHI) stake by 1.3% in Q2 2026, selling an estimated $91.5K and leaving 151,777 shares worth $7.24M. The position accounts for 0.03% of the portfolio, ranked #488.
MetLife Investment Management first reported a position in OHI in Q4 2017 and has held it in 35 quarters since. The position peaked at $14.2M in Q1 2019. 759 funds tracked by Wall St. Rank hold OHI as of Q2 2026.
- MetLife Investment Management held 151,777 shares of Omega Healthcare worth $7.24M as of Q2 2026.
- MetLife Investment Management sold 1,975 Omega Healthcare shares in Q2 2026, an estimated $91.5K.
- Omega Healthcare made up 0.03% of MetLife Investment Management's portfolio in Q2 2026, its #488 holding.
- MetLife Investment Management first reported a position in Omega Healthcare in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Omega Healthcare position peaked at $14.2M in Q1 2019.
- 759 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.